Testing dipyridamole to prevent low phosphate after kidney transplant
Treatments studied
Part of Hormones & metabolism clinical trials.
This trial tests if a drug called dipyridamole can prevent low phosphate levels after a kidney transplant. It is for adult kidney transplant patients who can safely take the drug.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (age 18 or older) getting a kidney transplant
- You do not have any known allergies or problems with dipyridamole
- You are not expected to need dialysis within the first week after transplant
- You are not currently taking Plavix, Eliquis, Xarelto, or warfarin (Coumadin)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if desmopressin can lower bleeding risk during a kidney transplant biopsy. It may help patients with reduced kidney function who need a biopsy.
This trial compares two treatment goals for blood phosphate levels in people with end-stage kidney disease who are on dialysis. It may help determine which target is safer and works better in real-world care.
This study tests antiplatelet medicines (like aspirin or clopidogrel) in people who have had a heart transplant. The goal is to see if these medicines can safely help prevent blood-related complications after transplant.
This trial studies whether a device called Dye-Vert Plus can lower the risk of kidney injury from contrast dye during heart catheter procedures (CAG and/or PCI). It focuses on people at higher kidney risk, especially those with diabetes or high blood pressure.
This trial tests whether taking dapagliflozin (a drug often used for diabetes and heart health) can help improve kidney structure and blood flow in people who received a kidney transplant at least 9 months ago. It may benefit those whose kidney function is stable, regardless of whether they have diabetes.
This trial tests if dipyridamole, a medication that affects blood flow, can help relieve restless legs syndrome (RLS) in people on hemodialysis. It may offer a new treatment option for RS related to kidney failure.
Hear when a new Hypophosphatemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.